Bristol-Myers Squibb Company (bmy)
BMY Earnings
Public earnings and growth snapshot for Bristol-Myers Squibb Company. Full earnings calendars, surprises, and multi-year history are available in Vest Terminal.
| Earnings growth (YoY) | 153.1% |
| Revenue growth (YoY) | 5.7% |
| Trailing P/E | 13.71 |
| Forward P/E | 9.31 |
| Last price | $61.15 |
| Market cap | $124.91B |
Start Free — open BMY in Vest Terminal
Access live data, filings, ownership, and analysis for Bristol-Myers Squibb Company.
Bristol-Myers Squibb Company FAQ
What does Bristol-Myers Squibb Company (BMY) do?
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Op…
What is BMY's P/E ratio?
Bristol-Myers Squibb Company has a trailing P/E of 13.71× based on publicly available market data.
Does BMY pay a dividend?
Indicated dividend yield: 4.0%. Confirm ex-dates and payout history in Vest Terminal.
What sector is BMY in?
Bristol-Myers Squibb Company is classified in Healthcare (Drug Manufacturers - General) on NYQ.
What is BMY's market capitalization?
Approximate market cap: $124.91B.
What are the main risks for BMY?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of BMY?
Potential positives include revenue growth of 5.7% year-over-year, earnings growth of 1.5% year-over-year.
Where can I get analyst estimates for BMY?
Public analyst price targets and consensus for Bristol-Myers Squibb Company are on the free /stocks/bmy/estimates page. Deeper estimate history and models are available in Vest Terminal.